Aimei Health Technology Co., Ltd. (AFJKR) Liabilities and Shareholders Equity (2023 - 2025)

Aimei Health Technology (AFJKR) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $12.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity fell 83.6% year-over-year to $12.1 million in Q4 2025; TTM through Dec 2025 was $145.7 million, a 49.71% decrease from a year earlier, with the FY2025 full-year figure at $12.1 million, down 83.6% from the prior year.
• Liabilities and Shareholders Equity was $12.1 million for Q4 2025 at Aimei Health Technology, down from $45.5 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $73.8 million in Q4 2024 and troughed at $12.1 million in Q4 2025.
• A 3-year average of $56.2 million and a median of $70.5 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity advanced 4.75% in 2024 and tumbled 83.6% in 2025, its largest moves.
• Over 3 years, Liabilities and Shareholders Equity stood at $70.5 million in 2023, then increased by 4.75% to $73.8 million in 2024, then plunged by 83.6% to $12.1 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $12.1 million (Q4 2025), $45.5 million (Q3 2025), and $44.6 million (Q2 2025), per Business Quant data.